Here is the list of Top Pharma Companies in India based on the Revenue in the recent Year before That take a Look at Pharma Industry
The global pharmaceutical market is expected to exceed USD 1.5 Trillion by 2023. India enjoys a key position in the global pharmaceutical industry. India is the world’s largest supplier of generics, accounting for 20% of global exports. It supplies over 50% of global demand for various vaccines and 40% of the demand for generic products in the US.
The domestic pharmaceutical market contributes to ~2% of the global industry in value and ~10% in volume terms. India’s pharmaceutical spending is predicted to grow at 8-11% CAGR in the 2019-23 period to reach a size of US$ 28-32 Billion.
List of Top Pharma Companies in India
Here is the list of Top 10 Pharma Company in India in the year 2019 based on total net sales. The list is in descending order.
10. Divi’s Laboratories Ltd
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. The company has a total net sales of Rs 4880 Crs.
- Market Cap: 57,919 Cr.
- ROE: 21.01 %
- Sales Growth (3Yrs): 9.41 %
- Promoter holding: 52.00 %
- Debt to equity: 0.00
- Price to book value: 8.18
Divi’s has been established for more than 29 years in Hyderabad, India with two manufacturing units and is among the top pharmaceutical companies in India. 11,000 highly trained professionals across departments and 350 scientists at Divi’s work together to bring world-class products to customers.
9. Alkem Laboratories Ltd
Established in 1973, high-quality branded generics, generic drugs, active pharmaceutical ingredients, and nutraceuticals, which the company markets in India and over 50 countries internationally.
With a comprehensive portfolio of over 750 brands covering all the major therapeutic segments and a robust pan-India sales and distribution network, The company is ranked amongst the top ten pharmaceutical companies in India in terms of domestic sales for the past 15 years.
- Market Cap: 30,691 Cr.
- ROE: 14.84 %
- Sales Growth (3Yrs): 14.47 %
- Promoter holding: 66.04 %
- Debt to equity: 0.24
- Price to book value: 5.22
The company have also been ranked the No.1 Anti-infective company in India for more than 10 years and feature amongst the leading pharmaceutical companies in the therapeutic segments of Gastro-intestinal, Pain management, and Vitamins / Minerals / Nutrients.
The company is currently ranked the sixth-largest pharmaceutical company in India in terms of domestic sales for the fiscal year 2018 with our iconic brands like Clavam, Pan, Pan-D, Taxim and Taxim-O featuring amongst the top 50 pharmaceutical brands in India.
Manufacturing footprint with a total of 21 manufacturing facilities including 19 in India and 2 the United States. The company has total net sales of Rs 5714 Cr.
8. Torrent Pharmaceuticals Ltd
Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in the therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI) and women healthcare (WHC).
The Company also has a significant presence in diabetology, pain management, gynecology, oncology, and anti-infective segments.
Torrent Pharma’s competitive advantage stems from the world-class manufacturing facilities, advanced R & D capabilities, extensive domestic network and a widespread global presence in over 40 countries. The company has total net sales of Rs 5762 Crs.
- Market Cap: 35,530 Cr.
- ROE: 12.75 %
- Sales Growth (3Yrs): 4.69 %
- Promoter holding: 71.25 %
- Debt to equity: 0.85
- Price to book value: 7.00
The acquisition of Elder Pharma’s Indian branded business in 2013, Dermaceutical business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, women healthcare brands from Novartis and Unichem’s Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma’s position in the Indian Pharma market.
Torrent Pharma started international acquisitions in 2005 with 90-year-old Heumann from Pfizer to enter the German market. Later on, Purchased ANDA of Monocycline from Ranbaxy for the US Market in 2015.
In January 2018, Torrent also acquired Bio-Pharm, Inc. (BPI) generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA.
7. Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
The company has several molecules in various stages of pre-clinical and clinical development and is primarily focused in the areas of Oncology, Respiratory and Dermatology.
- Market Cap: 7,505 Cr.
- ROE: 15.20 %
- Sales Growth (3Yrs): 9.27 %
- Promoter holding: 46.59 %
- Debt to equity: 0.60
- Price to book value: 1.27
The company has a total net sales of Rs 6403 Crs. It has 17 manufacturing facilities and 5 R&D centers dedicated to the goal of enriching lives across the globe. The Company is among the Top list of pharmaceutical companies in India
6. Cadila Healthcare Ltd
Zydus Cadila is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim in India and in the US and Brazil.
Zydus’ Innovation program is spearheaded by 1300 researchers across 19 sites, working on differentiated medicines for the future. From NCEs to vaccines, biosimilars, and niche technologies, the group is exploring different ideas and concepts, innovating constantly.
- Market Cap: 26,228 Cr.
- ROE: 18.66 %
- Sales Growth (3Yrs): 11.78 %
- Promoter holding: 74.88 %
- Debt to equity: 0.69
- Price to book value: 2.55
Zydus’ global business has a strong presence in the regulated markets of the US, Europe (France and Spain) and in the high profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide. The company has total sales of Rs 6500 Crs.
5. Dr Reddy’s Laboratories Ltd
Dr. Reddy’s Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India.
Dr. Reddy’s Laboratories Ltd has a 17.00 % Stock Weighatage in the Nifty Pharma Index. The company has total sales of Rs 14500 Crs. The company is the fifth-largest in the list of top ten pharma companies in India.
- Market Cap: 50,867 Cr.
- ROE: 13.61 %
- Sales Growth (3Yrs): -0.26 %
- Promoter holding: 26.76 %
- Debt to equity: 0.17
- Price to book value: 3.30
Dr. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. The Company is trusted by healthcare professionals and patients across geographies.
The Company has a total sales of Rs 16362 Cr. The Company is fourth-largest in the List of top ten pharma companies in India.
- Market Cap: 34,358 Cr.
- ROE: 9.62 %
- Sales Growth (3Yrs): 5.87 %
- Promoter holding: 36.65 %
- Debt to equity: 0.23
- Price to book value: 2.20
The company has strengthening global focus by consolidating and deepening presence in the key markets of India, South Africa, the US, and other economies of the emerging world.
Lupin is a global pharmaceutical company offering a wide range of products such as Branded & Generic Formulations, Biotechnology Products, Active Pharmaceutical Ingredients (APIs) and Specialty. The company has total sales of Rs 16718 Crs. Lupin’s world-class manufacturing facilities are spread across India, Japan, USA, Mexico, and Brazil.
- Market Cap: 29,497 Cr.
- ROE: 5.38 %
- Sales Growth (3Yrs): 5.46 %
- Promoter holding: 46.93 %
- Debt to equity: 0.64
- Price to book value: 2.17
Lupin is a significant player in the therapy areas of Gynaecology, Cardiovascular, Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Lupin also holds a global leadership position in the Anti-TB and Cephalosporins segments. With a presence in over 100 countries, Lupin offers high-quality yet affordable medicines for some of the most chronic diseases addressing unmet needs in many parts of the world.
2. Aurobindo Pharma Ltd
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. The company has total sales of Rs 19564 Cr.
- Market Cap: 27,615 Cr.
- ROE: 19.01 %
- Sales Growth (3Yrs): 12.41 %
- Promoter holding: 51.87 %
- Debt to equity: 0.37
- Price to book value: 1.82
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology, and anti-biotics, among others.
A fully integrated Pharma Company in India, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations.
Leveraging India’s globally competitive cost base and talented team of scientists
1. Sun Pharmaceuticals Industries Ltd
It is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. Sun Pharmaceutical Industries Ltd has a 24.09 % Stock Weighatage in Nifty Pharma. The company has total sales of Rs 29066 Cr.
- Market Cap: 94,378 Cr.
- ROE: 9.19 %
- Sales Growth (3Yrs): 0.67 %
- Promoter holding: 54.56 %
- Debt to equity: 0.25
- Price to book value: 2.28
The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology, and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.
Read more about Pharmaceuticals Industry in India.
Sun Pharma is the No 1 Pharma company in India in terms of Both Turnover and Market capital.
Pharma Companies in Hyderabad
- Aurobindo Pharma Ltd
- Divi’s Laboratories Ltd
- Dr Reddy’s Laboratories Ltd
- Sri Krishna Pharmaceuticals Limited
- Biological E. Limited
Pharma Companies in Bangalore
- Novo Nordisk India
- Lotus Labs Private Limited
- Terzetto Pharma Metrics
- Aurigene Discovery Technologies Limited
- Bal Pharma Limited
Pharma Companies in Chennai
- Sun Pharmaceuticals Industries Ltd.
- Medopharm Private Limited (Corporate Office)
- Orchid Pharma Ltd
- Tablets (India) Limited
- The Madras Pharmaceuticals